Response to marijuana as a function of potency and breathhold duration
- PMID: 2027922
- DOI: 10.1007/BF02244207
Response to marijuana as a function of potency and breathhold duration
Abstract
The present study examined the effects of systematic manipulation of breathhold duration (0 and 20 s) on the physiological and subjective response to active (M; 2.3% delta-9-THC) and placebo (P; 0.0% delta-9-THC) marijuana in a group of ten regular marijuana smokers. During the eight-session experiment, subjects were exposed twice to each of four experimental conditions (P0, P20, M0, M20), scheduled according to a randomized block design. A controlled smoking procedure was used in which the number of puffs and puff volume were held constant. Expired-air carbon monoxide (CO) levels were used to monitor smoke intake. Breathhold duration affected CO absorption; significantly more CO was absorbed from both P and M smoke after 20 s of breathholding (mean CO boost = 6.9 ppm) than after no breathholding (mean = 4.4 ppm). Heart rate was minimally affected by the breathhold manipulation. Effects of marijuana on mood were not consistently affected by breathhold duration. The results confirm previous findings that prolonged breathholding does not substantially enhance the effects of inhaled marijuana smoke.
Similar articles
-
Breathhold duration and response to marijuana smoke.Pharmacol Biochem Behav. 1989 Jun;33(2):481-4. doi: 10.1016/0091-3057(89)90534-0. Pharmacol Biochem Behav. 1989. PMID: 2554344 Clinical Trial.
-
Marijuana smoking: effects of varying puff volume and breathhold duration.J Pharmacol Exp Ther. 1995 Feb;272(2):560-9. J Pharmacol Exp Ther. 1995. PMID: 7853169
-
Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC.Pharmacol Biochem Behav. 1991 Nov;40(3):651-6. doi: 10.1016/0091-3057(91)90377-e. Pharmacol Biochem Behav. 1991. PMID: 1666923
-
Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette.Pharmacol Biochem Behav. 1991 Nov;40(3):657-61. doi: 10.1016/0091-3057(91)90378-f. Pharmacol Biochem Behav. 1991. PMID: 1666924
-
Marijuana's dose-dependent effects in daily marijuana smokers.Exp Clin Psychopharmacol. 2013 Aug;21(4):287-93. doi: 10.1037/a0033661. Exp Clin Psychopharmacol. 2013. PMID: 23937597 Free PMC article. Clinical Trial.
Cited by
-
Challenges in quantifying marijuana use.Am J Addict. 2009 Mar-Apr;18(2):178-9. doi: 10.1080/10550490902772579. Am J Addict. 2009. PMID: 19283572 Free PMC article. No abstract available.
-
Δ9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial.Neuropsychopharmacology. 2020 Oct;45(11):1807-1816. doi: 10.1038/s41386-020-0690-3. Epub 2020 May 9. Neuropsychopharmacology. 2020. PMID: 32386395 Free PMC article. Clinical Trial.
-
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.Addict Biol. 2008 Jun;13(2):188-95. doi: 10.1111/j.1369-1600.2007.00095.x. Epub 2008 Feb 14. Addict Biol. 2008. PMID: 18279497 Free PMC article. Review.
-
Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans.Psychopharmacology (Berl). 1992;107(2-3):255-62. doi: 10.1007/BF02245145. Psychopharmacology (Berl). 1992. PMID: 1319601 Clinical Trial.
-
Characterizing smoking topography of cannabis in heavy users.Psychopharmacology (Berl). 2012 Mar;220(2):309-18. doi: 10.1007/s00213-011-2480-4. Epub 2011 Sep 16. Psychopharmacology (Berl). 2012. PMID: 21922170 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources